Name : Nuvation Bio Inc
Current / Former Name: Panacea Acquisition Corp. (Predecessor)
Address: 1500 Owens Street, Suite 515, San Francisco, CA 94158
Phone Number: (415) 578-5035
Investor Relations Contact: ir@nuvationbio.com
Website - https://www.nuvationbio.com
Warrant Details
Warrant Symbol: NUVB.WS
Warrants Listed: 4,312,500
Ratio: 1-for-1
Cusip Number: 67079M 11 2
ISIN Number: US67079Z1121
Parent Stock Symbol: NUVB (NYSE)
Underlying Stock Cusip: 67079Z 10 4
675
Expiry Date - February 10, 2026
Exercise Price: $11.50 USD
Synopsis & Listing Information
Nuvation Bio Inc. is a clinical-stage biopharmaceutical enterprise focused on development strategies for a proprietary pipeline of targeted oncology therapeutic candidates engineered to tackle difficult-to-treat cancers.
Listing History: The financial structure entered the public markets via the initial public offering of Panacea Acquisition Corp. (sponsored by EcoR1 Capital) on June 30, 2020. Public warrants began independent trading on the NYSE under symbol PANA.WS.
Business Combination: On February 10, 2021, Panacea Acquisition Corp. completed its business combination transaction with private oncology developer Nuvation Bio Inc.
Ticker Change: In connection with the transaction closing, the market symbols changed on the New York Stock Exchange. The common stock transitioned to NUVB, and the tradeable public warrants migrated from PANA.WS to the permanent tracking symbol NUVB.WS.
Reverse Split Adjustment: N/A
Current Status: The warrants arrived at their planned five-year post-merger contractual lifespan and officially expired out of circulation on February 10, 2026, holding no remaining equity value.
Current / Former Name: Panacea Acquisition Corp. (Predecessor)
Address: 1500 Owens Street, Suite 515, San Francisco, CA 94158
Phone Number: (415) 578-5035
Investor Relations Contact: ir@nuvationbio.com
Website - https://www.nuvationbio.com
Warrant Details
Warrant Symbol: NUVB.WS
Warrants Listed: 4,312,500
Ratio: 1-for-1
Cusip Number: 67079M 11 2
ISIN Number: US67079Z1121
Parent Stock Symbol: NUVB (NYSE)
Underlying Stock Cusip: 67079Z 10 4
675
Expiry Date - February 10, 2026
Exercise Price: $11.50 USD
Synopsis & Listing Information
Nuvation Bio Inc. is a clinical-stage biopharmaceutical enterprise focused on development strategies for a proprietary pipeline of targeted oncology therapeutic candidates engineered to tackle difficult-to-treat cancers.
Listing History: The financial structure entered the public markets via the initial public offering of Panacea Acquisition Corp. (sponsored by EcoR1 Capital) on June 30, 2020. Public warrants began independent trading on the NYSE under symbol PANA.WS.
Business Combination: On February 10, 2021, Panacea Acquisition Corp. completed its business combination transaction with private oncology developer Nuvation Bio Inc.
Ticker Change: In connection with the transaction closing, the market symbols changed on the New York Stock Exchange. The common stock transitioned to NUVB, and the tradeable public warrants migrated from PANA.WS to the permanent tracking symbol NUVB.WS.
Reverse Split Adjustment: N/A
Current Status: The warrants arrived at their planned five-year post-merger contractual lifespan and officially expired out of circulation on February 10, 2026, holding no remaining equity value.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...